Immunoglobulin Replacement Therapy in Secondary Hypogammaglobulinemia

Immunoglobulin (Ig) replacement therapy dramatically changed the clinical course of primary hypogammaglobulinemias, significantly reducing the incidence of infectious events. Over the last two decades its use has been extended to secondary antibody deficiencies, particularly those related to hematol...

Descripción completa

Detalles Bibliográficos
Autores principales: Compagno, Nicolò, Malipiero, Giacomo, Cinetto, Francesco, Agostini, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259107/
https://www.ncbi.nlm.nih.gov/pubmed/25538710
http://dx.doi.org/10.3389/fimmu.2014.00626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259107/
https://www.ncbi.nlm.nih.gov/pubmed/25538710
http://dx.doi.org/10.3389/fimmu.2014.00626

Ejemplares similares